Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 11 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $96K 337 sh |
| Oct 8, 2026 traded Oct 6, 2026 |
| 11 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $52K 183 sh | Oct 8, 2026 traded Oct 6, 2026 |
| 11 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $91K 320 sh | Oct 8, 2026 traded Oct 6, 2026 |
| 11 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $102K 361 sh | Oct 8, 2026 traded Oct 6, 2026 |
| 11 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $77K 280 sh | Oct 8, 2026 traded Oct 7, 2026 |
| 11 | Hata Yujiro SDirector, President and CEO |  IDYAIDEAYA Biosciences, Inc.Open-market sale · 10b5-1 plan | SELL | $955K 25.5K sh | Oct 8, 2026 traded Oct 6, 2026 |
| 11 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $168K 600 sh | Oct 8, 2026 traded Oct 6, 2026 |
| 11 | Calkins Matthew WDirector, CEO and President, 10% Owner |  APPNAPPIAN CORPOpen-market sale · 10b5-1 plan | SELL | $471K 12.4K sh | Oct 8, 2026 traded Oct 7, 2026 |
| 11 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $84K 305 sh | Oct 8, 2026 traded Oct 7, 2026 |
| 11 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $220K 800 sh | Oct 8, 2026 traded Oct 7, 2026 |
| 9 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $314K 11.9K sh | Oct 8, 2026 traded Oct 7, 2026 |
| 9 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $257K 9,381 sh | Oct 8, 2026 traded Oct 6, 2026 |
| 9 | Haro AlexDirector |  LIFLife360, Inc.Open-market sale · 10b5-1 plan | SELL | $59K 1,392 sh | Oct 8, 2026 traded Oct 6, 2026 |
| 9 | Bobulsky SusanChief Commercial Officer, MRD | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $193K 6,444 sh | Oct 8, 2026 traded Oct 6, 2026 |
| 9 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $305K 11.9K sh | Oct 8, 2026 traded Oct 8, 2026 |
| 8 | Agrawal NitinChief Financial Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $266 3 sh | Oct 8, 2026 traded Oct 6, 2026 |
| 8 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $33K 120 sh | Oct 8, 2026 traded Oct 6, 2026 |
| 5 | Hata Yujiro SDirector, President and CEO | IDYAIDEAYA Biosciences, Inc. Open-market sale · 10b5-1 plan | SELL | $31K 800 sh | Oct 8, 2026 traded Oct 6, 2026 |
| 5 | Gryzlov YuryCHIEF OPERATING OFFICER |  GDYNGRID DYNAMICS HOLDINGS, INC.Open-market sale · 10b5-1 plan | SELL | $39K 4,849 sh | Oct 8, 2026 traded Oct 8, 2026 |
| 3 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $27K 901 sh | Oct 8, 2026 traded Oct 6, 2026 |
| 3 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $31K 1,100 sh | Oct 8, 2026 traded Oct 6, 2026 |
| 3 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $15K 499 sh | Oct 8, 2026 traded Oct 6, 2026 |
| 1 | Hug JoshuaDirector |  RELYRemitly Global, Inc.Open-market sale · 10b5-1 plan | SELL | $127K 5,500 sh | Oct 8, 2026 traded Oct 7, 2026 |
| 1 | Eberwein Jeffrey E.Director, Chief Executive Officer, 10% Owner |  STRRStar Equity Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $9,170 1,000 sh | Oct 8, 2026 traded Oct 8, 2026 |
| 1 | Eberwein Jeffrey E.Director, Chief Executive Officer, 10% Owner | STRRStar Equity Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $9,200 1,000 sh | Oct 8, 2026 traded Oct 6, 2026 |
| 1 | Hug JoshuaDirector | RELYRemitly Global, Inc. Open-market sale · 10b5-1 plan | SELL | $127K 5,500 sh | Oct 8, 2026 traded Oct 6, 2026 |
| 1 | Eberwein Jeffrey E.Director, Chief Executive Officer, 10% Owner | STRRStar Equity Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $9,170 1,000 sh | Oct 8, 2026 traded Oct 7, 2026 |
| 63 | Barcos Melgar PabloVP INVESTMENT OFFICER |  VTMXVesta Real Estate Corporation, S.A.B. de C.V.Open-market sale | SELL | $22K 6,154 sh | Oct 7, 2026 traded Aug 25, 2026 |
| 49 | Knotnerus Tim JasperDirector, Chief Executive Officer |  AGMBAgomAb Therapeutics NVOpen-market purchase | BUY | $51K 6,000 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 46 | Kemula Pierre Thadee VictorChief Financial Officer | AGMBAgomAb Therapeutics NV Open-market purchase | BUY | $26K 3,000 sh | Oct 7, 2026 traded Oct 6, 2026 |
| 46 | Kemula Pierre Thadee VictorChief Financial Officer | AGMBAgomAb Therapeutics NV Open-market purchase | BUY | $43K 5,000 sh | Oct 7, 2026 traded Oct 6, 2026 |
| 42 | Kemula Pierre Thadee VictorChief Financial Officer | AGMBAgomAb Therapeutics NV Open-market purchase | BUY | $17K 2,000 sh | Oct 7, 2026 traded Oct 6, 2026 |
| 40 | Partridge Andrew JohnChief Growth Officer |  GRALGRAIL, Inc.Open-market sale | SELL | $1.15M 7,873 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 40 | Freidin AaronChief Financial Officer | GRALGRAIL, Inc. Open-market sale | SELL | $3.46M 23.6K sh | Oct 7, 2026 traded Oct 5, 2026 |
| 40 | Nilan Nicholas WilliamGeneral Manager-US |  ARQQArqit Quantum Inc.Open-market sale | SELL | $12K 522 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 40 | Brockman IvanDirector |  VRAVera Bradley, Inc.Open-market purchase | BUY | $50K 10.0K sh | Oct 7, 2026 traded Oct 6, 2026 |
| 38 | Partners Group Private Equity II, LLCAffiliate of the Adviser | NAPartners Group Private Equity Fund, LLC Open-market sale | SELL | $29.96M 13.62M sh | Oct 7, 2026 traded Oct 1, 2026 |
| 38 | Knotnerus Tim JasperDirector, Chief Executive Officer | AGMBAgomAb Therapeutics NV Open-market purchase | BUY | $44K 5,000 sh | Oct 7, 2026 traded Oct 6, 2026 |
| 38 | Troim Tor OlavDirector |  BORRBorr Drilling LtdOpen-market purchase | BUY | $6.36M 1.50M sh | Oct 7, 2026 traded Oct 6, 2026 |
| 37 |  Tenev VladimirDirector, Chief Executive Officer | HOODRobinhood Markets, Inc. Open-market sale · 10b5-1 plan | SELL | $22.10M 193.9K sh | Oct 7, 2026 traded Oct 5, 2026 |
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01MARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
BCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K